Neuroone Medical Technologies Corp at Noble Capital Markets Investor Conference (Virtual) Transcript
Good morning, everyone. Thanks for joining me at the NobleCon Conference. My name is Dave Rosa. I'm the CEO of NeuroOne Medical Technologies Corporation. We are a NASDAQ-listed company in the field of neurology. I'm going to put up here just the forward-looking statement because we are a public company. I'm sure you've all seen that many times.
So in terms of what NeuroOne does, as I mentioned, we're a company in the neurology, space as well as neurosurgery, and we make electrodes that are used for neurosurgical procedures. So everything from epilepsy to Parkinson's disease.
One of the newer fields is depression, back pain due to failed back surgeries, multiple failed back surgeries. And there's many other indications that we're not focused on right now, but from a platform standpoint, would apply. Urinary incontinence is certainly one of them. High blood pressure is another.
What these devices do, just to be clear, is they perform multiple functions. So in the brain, what they'll do is record
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |